AstraZeneca, Daiichi Sankyo Say FDA Has Accepted Enhertu for Priority Review | MarketScreener

Retrieved on: 2022-04-19 12:53:37

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, Daiichi Sankyo Say FDA Has Accepted Enhertu for Priority Review | MarketScreener. View article details on hiswai:

Excerpt

AstraZeneca PLC and Daiichi Sankyo Co. said Tuesday that Enhertu, a cancer treatment, has been accepted by the U.S. Food and Drug Administration ...

Article found on: www.marketscreener.com